Metta Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 26-07-2024
- Paid Up Capital ₹ 5.00 Cr
as on 26-07-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 26-07-2024
- Revenue -4.50%
(FY 2023)
- Profit -20.85%
(FY 2023)
- Ebitda -17.15%
(FY 2023)
- Net Worth -129.83%
(FY 2023)
- Total Assets -38.49%
(FY 2023)
About Metta Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹4.00 Cr.
Nishant Menon, Ravindra Pasta, and Ravindra Menon serve as directors at the Company.
- CIN/LLPIN
U74900MH2010FTC203459
- Company No.
203459
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
24 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Santacruz West, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Metta Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishant Menon  | Additional Director | 11-May-2024 | Current |
| Ravindra Pasta | Director | 23-Aug-2017 | Current |
| Ravindra Menon | Director | 24-May-2010 | Current |
Financial Performance and Corporate Structure Insights of Metta Life Sciences.
Metta Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.5% decrease. The company also saw a substantial fall in profitability, with a 20.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 129.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Metta Life Sciences?
In 2023, Metta Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apcer Life Sciences India LimitedActive 15 years 9 monthsRavindra Pasta and Ravindra Menon are mutual person
Apc Pharmaceuticals And Chemicals Private LimitedActive 29 years 11 monthsNishant Menon, Ravindra Pasta and 1 more are mutual person
Apc Nutrients Private LimitedActive 18 years 11 monthsRavindra Pasta and Ravindra Menon are mutual person
- Drinkasaur Software & Listings Private LimitedActive 10 years 2 months
Nishant Menon is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Sep 2021 | ₹4.00 Cr | Open |
How Many Employees Work at Metta Life Sciences?
Metta Life Sciences has a workforce of 30 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Metta Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metta Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
